Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  bleomycin sulfate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 486 for your search:
Start Over
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EU-HNBE-2003, NCT00198263
Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EU-CCBE-2003, NCT00198276
Combination Chemotherapy in Treating Men With Germ Cell Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 16 to 50
Sponsor: Other
Protocol IDs: EORTC-30983, NCT00003643
Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
Phase II Chemotherapy with MTX/CF, Aminopterin or M-BACOD plus CTX or BCG Immunotherapy for Advanced non-Hodgkin's Lymphoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 25 to 65
Sponsor:
Protocol IDs: DFCI-75116
Phase II/III Induction Chemotherapy with CACP/BLEO/MTX/CF vs CACP/5-FU for Stage II/III/IV, Previously Untreated Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 09/88)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DFCI-83084, NCI-T84-0282D, T84-0282
High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: IIL-HD0801, EudracT Number 2008-002684-14, NCT00784537
Phase III Randomized Study of CDDP/IFF vs BIP (BLEO/IFF/CDDP) in Patients with Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: GOG-149, GOG-0149
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, DM94-017, T94-0040, NCT00002565
Phase III Randomized Study of Radiotherapy with vs without BLEO/MITO/CDDP/VP-16 for Locally Advanced Squamous Cell Carcinoma of the Cervix (Summary Last Modified 08/94)
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: FRE-FNCLCC-CO-II, NCI-F94-0020
Phase III Randomized Study of BEP (BLEO/VP-16/CDDP) in Good-Prognosis Germ Cell Cancer: 3 vs 4 Courses and Equivalent Doses Over 3 vs 5 Days/Course
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: EORTC-30941, MRC-TE20, EU-95004
Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: 9426, POG-9426, CCG-P9426, CDR0000065013, COG-9426, NCT00002827
Combination Chemotherapy in Treating Patients With Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065154, E-8592, NCCTG-942853, NCI-P96-0076, NCT00002872
Phase III Randomized Study of Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin (BEP) in Good-Prognosis Advanced Germ Cell Cancer (Summary Last Modified 03/2000)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-T93BP, FRE-T93BP, EU-96016
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: 9425, COG-9425, CDR0000065359, P9425, POG-9425, NCT00005578
Start Over